Fibroblast growth factor 21: A "rheostat" for metabolic regulation?

Qin-Ying She1, Jing-Fu Bao2, Hui-Zhen Wang2

  • 1Department of Endocrinology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510999, China; Department of Nephrology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510999, China.

Insights

Fibroblast growth factor 21 (FGF21) helps maintain metabolic balance by regulating nutrient fluctuations. Its therapeutic potential for metabolic disorders needs further investigation due to variable clinical trial outcomes.

Area of Science:

  • Endocrinology
  • Metabolic Regulation
  • Nutritional Science

Background:

  • Fibroblast growth factor 21 (FGF21) is a key regulator of metabolic homeostasis, with significant research over two decades elucidating its roles.
  • FGF21's potential as a therapeutic agent for metabolic disorders has been explored, yet clinical trial results have been inconsistent.
  • FGF21 is influenced by nutrient intake and released by the liver and adipose tissue, impacting appetite and energy metabolism.

Purpose of the Study:

  • To re-evaluate the role of FGF21 beyond simple anti-diabetic or anti-obesity effects.
  • To propose a revised understanding of FGF21 as a nutrient-balancing factor crucial for energy supply.
  • To highlight the context-dependent nature of FGF21's functions in glycometabolism and lipometabolism.

Main Methods:

  • Review and synthesis of existing research on FGF21's physiological roles and clinical trial data.
  • Analysis of FGF21's regulatory pathways involving nutrient sensing and hormonal signaling.
  • Comparative assessment of FGF21's effects across different metabolic states.

Main Results:

  • FGF21 dynamically responds to nutrient availability and influences central and peripheral metabolic tissues.
  • Evidence suggests FGF21's primary function is to balance nutrient fluctuations for energy homeostasis.
  • Clinical efficacy of FGF21 appears contingent on the specific metabolic context, explaining variable trial outcomes.

Conclusions:

  • FGF21 should be viewed as a critical mediator of nutrient balance rather than solely an anti-obesity or anti-hyperglycemia agent.
  • The pharmacological application of FGF21 requires careful consideration of the patient's metabolic state.
  • Further research is needed to optimize FGF21-based therapies by accounting for its context-dependent actions.

Related Concept Videos

Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
10.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.7K